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Abstract
Background: From 2006 to 2010, France experienced two bluetongue epidemics caused by serotype 1 (BTV-1) and 8
(BTV-8) which were controlled by mass vaccination campaigns. After five years without any detected cases, a sick ram
was confirmed in August 2015 to be infected by a BTV-8 strain almost identical to that circulating during the previous
outbreak. By then, part of the French cattle population was expected to be still protected, since bluetongue antibodies
are known to last for many years after natural infection or vaccination. The objective of this study was to estimate the
proportion of cattle in France still immune to BTV-8 at the time of its re-emergence in 2015.
Results: We used BTV group-specific cELISA results from 8525 cattle born before the vaccination ban in 2013 and
15,799 cattle born after the ban. Samples were collected from January to April 2016 to estimate seroprevalence per
birth cohort. The overall seroprevalence in cattle at national and local levels was extrapolated from seroprevalence
results per birth cohort and their respective proportion at each level. To indirectly assess pre-immune status of birth
cohorts, we computed prevalence per birth cohort on infected farms in autumn 2015 using 1377 RT-PCR results. These
revealed limited BTV circulation in 2015. Seroprevalence per birth cohort was likely to be connected to past exposure
to natural infection and/or vaccination with higher seroprevalence levels in older animals. A seroprevalence of 95% was
observed for animals born before 2008, of which > 90% were exposed to two compulsory vaccination campaigns in
2008-2010. None of the animals born before 2008 were found to be infected, unlike 19% of the young cattle which
had never been vaccinated. This suggests that most ELISA-positive animals were pre-immune to BTV-8. We estimated
that 18% (from 12% to 32% per département) of the French cattle population was probably pre-immune in 2015.
Conclusions: These results strongly suggest a persistence of antibodies for at least 5-6 years after natural infection or
vaccination. The herd immunity of the French cattle population probably limited BTV circulation up to 2015, by which
time more than 80% of cattle were naive.
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Background
Bluetongue (BT) is a vector-borne viral disease of wild
and domestic ruminants that can cause major losses in
ruminant production especially in sheep. The BT virus
(BTV) is transmitted by several species of biting midges
of the genus Culicoides. To date, 27 BTV-serotypes have
been identified [1]. In 2006, the emergence of BTV
serotype 8 (BTV-8) in northern Europe initiated a wide-
spread epidemic from 2006 to 2009 in central and west-
ern Europe [2]. In France, BTV-8 was introduced by the
end of 2006 from Belgium and spread over most of the
country, infecting at least 42,850 farms between 2006
and 2009 [3]. During the same period, France experi-
enced another BT epidemic with BTV serotype 1 (BTV-
1), first detected in November 2007 close to the Spanish
border. BTV-1 mainly circulated in south-western
France, although a few infected (i.e. RT-PCR positive)
animals were later discovered throughout France,
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without clear evidence of any local BTV circulation.
Two years of mandatory vaccination followed by two
voluntary campaigns were launched against both sero-
types in throughout the French mainland from Novem-
ber 2008 to April 2010, and from November 2010 to
April 2012 respectively. The cattle vaccination coverage
against both serotypes was estimated to be 80% in 2008-
2009, 90% in 2009-2010 and 25-30% in 2010-2011 [3, 4].
The vaccination coverage is unknown for 2011-2012 but
assumed to be lower than in 2010-2011 due to both lack
of interest and reluctance by farmers. The number of out-
breaks drastically decreased in 2009 probably due to the
high proportion of naturally infected (and thus immu-
nised) and vaccinated animals. The last BTV-8 and BTV-1
outbreaks were detected respectively in December 2009
and June 2010, and mainland France officially recovered a
BT-free status in December 2012. Vaccination was banned
in mainland France on 31th May 2013.
On 11th September 2015, French authorities notified to
the OIE a BTV-8 outbreak in the Allier département in
central France. The virus was detected in a 5-year-old ram
which showed clinical signs evocative of BT. The virus’s
genetic sequence was 99.9% similar to the virus circulating
in 2006-2009 [5]. BTV-8 eradication through mandatory
vaccination was not carried out in France in 2015. The
limited amount of vaccines available in 2015-2016 was
mainly used for animals leaving the restriction zone (i.e.
within 150 km of outbreaks). From August 2015 to June
2016, 284 outbreaks were detected through pre-export
tests (74%), active surveillance (21%) and clinical surveil-
lance (5%), and were mainly located in the centre of
France (the Allier and Puy-de-Dôme départements).
One of the main hypotheses for the resurgence of
BTV-8 in France is that the virus had been circulating at
low levels since 2009 and had remained undetected by
the surveillance system [6–8]. Like other viral diseases,
the intensity of BTV circulation may have increased
along with the increasing proportion of naive animals
due to ruminant population turn-over and/or loss of im-
munity. One can expect resurgence to occur when the
proportion of naive animals towards BTV-8 is suffi-
ciently high to lead to more intensive viral circulation
and spread, but the value of this threshold is unknown.
Cattle are much more attractive to Culicoïdes spp. than
are sheep [9, 10] and hence more frequently infected by
BT viruses [11]. They are considered as the primary res-
ervoir and amplifying host for the virus [12, 13]. In
France, they are much more numerous than sheep, with
19.2 and 7 million of head respectively (source: the
French Livestock Institute Idele and GEB). By July 2015,
23% of the French cattle population was composed of
animals born before 2010, which had therefore been
present during the mandatory vaccination campaigns of
2008-2010 (source: National Identification Database
BDNI). Some of these animals might still be immune to
BTV-8, but their proportion was unknown. Such data is
not available for sheep.
The duration of BTV-8 immunity acquired after nat-
ural infection or vaccination and how it decreases over
time depends on several factors. The protective immune
status of animals with respect to BTV is generally
assessed via their humoral immune response, even
though cellular immune response might also be a deter-
minant [14–17]. Although neutralising type-specific
antibodies are generally preferred for estimating BT pro-
tective immune status, group-specific antibodies de-
tected by ELISA can also be used to infer the immune
status of animals against a serotype if this one serotype
has been circulating or was targeted for vaccination in
the area. Seroneutralising and ELISA results are rela-
tively well correlated, although the proportion of ELISA
positive results is generally higher [18–21]. Neutralising
and group-specific antibodies against BTV-8 have been
detected in cattle four years after natural infection and
vaccination [18, 21–23]. However, different studies have
observed large variation in the proportion of seropositive
animals one year after vaccination ranging from 60% to
97% when evaluated by ELISA [18–20, 24–28]. Such a
variation could be explained by a difference in the vac-
cination protocol (e.g. with or without a booster vaccin-
ation), the type of vaccine itself or the mean age of
animals at vaccination [27]. In France, several inactivated
commercial vaccines against BTV-8 and BTV-1 were
successively used from 2008 to 2012 (Table 1). Accord-
ing to their birth date, animals received from one to sev-
eral doses against serotype 1 or 8 (Table 2). All these
factors may have influenced the proportion of cattle still
immune in France in 2015, and made it difficult to infer
this proportion without further investigation.
The objective of this paper was to estimate the propor-
tion of cattle still immune to BTV-8 in France in 2015 at
national and local levels. This was essential to better
understand BT epidemiology and to empirically estimate
the threshold levels of the proportion of naive animals in
the cattle population required for BTV to re-emerge and
spread at a detectable level. This was also important to
better tailor surveillance measures and to provide advice
on vaccination to French farmers. Considering the ex-
pected differences in exposure to viral infection over
time and the successive vaccination protocols (Table 2),
we estimated the proportion of seropositive cattle per
birth cohort (see definition below) in winter 2015-2016
using a BTV group-specific competitive ELISA of 15,799
cattle and extrapolated it to the cattle population as a
whole. In order to check the hypothesis that infection
prevalence in autumn 2015 was lower in birth cohorts
which were the more exposed to BTV-8 infection or
vaccination, we estimated the proportion of cattle
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positive to BTV-8 by RT-PCR per birth cohort on in-
fected farms in autumn 2015. According to this hypoth-
esis, we expected to find a lower number of infected
animals in older birth cohorts.
Methods
Estimates of seroprevalence in cattle per birth cohort and
the département’s BTV-8 status in 2015
Definition of birth cohorts and status of BTV-8 infected/
non-infected areas
Given the differences in cattle exposure to BTV-8 and
the different vaccination protocols implemented from
2007 to 2016, seroprevalence was expected to vary be-
tween animal birth dates (Table 2). We defined annual
birth cohorts from 1st July to 30th June of the following
year in order to take into account the period of BTV cir-
culation (mainly from July to November, with a detec-
tion window by RT-PCR up to six months post-infection
in cattle, i.e. up to May-June) and of vaccination cam-
paigns (conducted during annual surveillance sampling
for brucellosis and infectious bovine rhinotracheitis from
October to April).
In order to estimate seroprevalence levels before and
after the 2015 resurgence, seroprevalence per birth co-
hort was estimated separately for areas “infected” and
“non-infected” by BTV-8 in 2015-2016. To define in-
fected and non-infected areas, we chose the “départe-
ment”, the French administrative unit that is also the
geographical area for BT management. A département
was considered “infected” in 2015 when at least one
animal was found RT-PCR-positive by the surveillance
system between 1st August 2015 and 30th June 2016
[29]. It is worth noting that a very high number of cattle
from France (> 140,000) were tested by RT-PCR mainly
for pre-export tests during this period. Blood samples
were tested by a BTV group-specific RT-PCR and posi-
tive samples were then screened with a BTV-8 type-
specific RT-PCR. These analyses were carried out by
local veterinary laboratories. Results with a Ct value be-
tween 35 and 39 were confirmed by the National Refer-
ence Laboratory (ANSES, Maisons-Alfort). Given the
long persistence of BT antibodies post-infection detected
by ELISA, and the detection of viral genome up to six
months post-infection by RT-PCR [30, 31], we used RT-
PCR-positive results as a proof of an infection occurring
in 2015-2016. The date of 30th June was defined as the
end of the estimated period of the detection of the virus
circulation in 2015-2016 considering several criteria: no
vector activity between January to April-May [32], the
possible detection of viral genome by RT-PCR up to
6 months post-infection [30, 31], an increase in the num-
ber of outbreaks associated with a decrease in Ct values of
RT-PCR-positive results in July compared to previous
months and first virus isolation in August 2016 [29].
Départements located in the main BTV-1 infected area
in 2007-2008 (South-West France) were excluded to re-
move potential effects of past BTV-1 circulation on the
antibody response of cattle to BTV-8, although a cross-
immunity between these two serotypes is not expected
[33]. In other départements we considered that BTV-1
Table 1 Vaccine products used from 2008 to 2013 in France against BTV-8 and BTV-1 in cattle
Year BTV-8 vaccine BTV-1 vaccine
2008-2009 (mandatory
vaccination campaign)
Bovilis BTV-8® (Intervet, The Netherlands) Zulvac® 1 Bovis (Fort Dodge Animal health, The
Netherlands),Bluevac® 1 (CZ Veterinaria S.A., Spain)
2009-2010 (mandatory
vaccination campaign)
BTVPUR® AlSap 8 (Merial, France) Zulvac® 1 Bovis (Fort Dodge Animal health, The
Netherlands), Bluevac® 1 (CZ Veterinaria S.A., Spain)
2010-2013 (voluntary
vaccination campaign)
BTVPUR® AlSap 8, Bovilis BTV-8®, Zulvac® 8 Bovis (Fort
Dodge Animal health, The Netherlands)
BTVPUR® AlSap 1, Bluevac® 1, Zulvac® 1 Bovis
Table 2 Exposure to BTV-8 and vaccination campaign characteristics per cattle birth cohort in France












< July 2008 Yes Yes Yes Yes Yes
July 2008 - June 2009 Yes Calves* Yes Yes Yes
July 2009 - June 2010 No No Calves* Yes Yes
July 2010 - June 2011 No No No Calves* Yes
July 2011 - June 2012 No No No No Calves*
July 2012 - June 2013 No No No No No
> June 2013 No No No No No
*Cattle up to 12 months-old
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circulation in 2007-2010 was too small to have a big influ-
ence on the response of BTV-8 antibodies. Départements
with less than 20,000 cattle were also excluded (Fig. 1).
Sampling design
For cattle born after January 2013, we used data col-
lected from the national serological survey organised by
the French Ministry of Agriculture and carried out from
December 2015 to March 2016 (see technical instruction
DGAL/SDSPA/2016-35). Its objectives were to detect
the presence of BTV in uninfected départements and to
demonstrate seasonally-free zones of BT within the re-
striction zone. Animals born after January 2013 were tar-
geted as they were considered to be naive and not
vaccinated against BT; calves of less than 12 months old
were excluded due to the potential persistence of colos-
tral antibodies [34]. Between 167 and 680 cattle from 11
to 47 farms were sampled per département, according to
the sampling scheme (Additional file 1).
For cattle born before January 2013, sampling was
organised at the same time as the national survey of
young animals in the winter of 2015-2016. The sampling
scheme was adapted to practical and financial con-
straints inherent to surveillance programmes, especially
in the context of re-emergence when animal health offi-
cers in the field are regularly asked to conduct surveys/
investigations. More specifically, it was designed to limit
the amount of work required of them and avoid delaying
BT investigation in young animals. Therefore, the sam-
pling scheme was not stratified per birth cohort. Ten
farms were randomly selected per département and 15
animals not vaccinated in 2015 were randomly sampled
per farm in order to reach 150 animals per département.
This number was considered sufficient to have good es-
timates of the seroprevalence per birth cohort and per
BTV-8 département status in 2015.
Serological analyses
BTV antibodies were detected in cattle serum by certi-
fied local veterinary laboratories using one of the
authorised competitive ELISAs. Of the 37 laboratories
involved in the surveillance system, 33 used ID Screen
Bluetongue Competition (ID VET, France) and four used
IDEXX Bluetongue Competition Ab (IDEXX, United
Kingdom) (4% of the analyses). Analyses were performed
and interpreted according to the manufacturers’ instruc-
tions. For the ID-VET kit, samples with a competition
percentage ≤ 35%,]35 -45%], > 45% were considered posi-
tive, doubtful or negative in that order. For the IDEXX
kit, samples with a competition percentage ≤ 70%,]70 -
80%], and > 80% were considered positive, doubtful or
negative in that order.
Seroprevalence estimates per birth cohort at national and
regional levels
Animals that had moved from one département to an-
other after July 2015 — considered the potential begin-
ning of BTV circulation in 2015-2016 — were excluded
from the analysis.
Fig. 1 Study area of the 2015 BTV seroprevalence survey in France. In colour, the départements (thin black lines) and regions (thick black lines)
included in the survey. In grey, départements excluded from the survey because of the low number of cattle or BTV-1 circulation in 2007-2008 to
remove the effects of past BTV-1 circulation on the antibody response of cattle to BTV-8
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We calculated seroprevalence per birth cohort and
département status (infected vs. non-infected in 2015-
2016 as defined above) at national level. Confidence in-
tervals of 95% (95% CI) were calculated using exact bi-
nomial law. Seroprevalences values of birth cohorts and
départment status were compared with the Chi2 test.
In order to assess if seroprevalence per birth cohort was
spatially heterogeneous in 2015, we calculated seropreva-
lence and its 95% CI per birth cohort and region (an ad-
ministrative unit including several départements; see Fig.
1). This analysis was carried out per region in order to
reach a sufficient number of animals per birth cohort to
enable birth period seroprevalence estimates within +/−
10%. The median and the range proportion of seropreva-
lence per birth cohort and per region, and the median
range of the seroprevalence’s 95% CI were then calculated.
Estimates of the seroprevalence of cattle population in
France in 2015 at national, regional and département
levels
As the distribution of birth cohorts is spatially hetergen-
ous in France, we estimated the overall seroprevalence
at three geographical levels: national, regional and
département levels. To do so, we combined the estimate
of the seroprevalence per birth cohort and the propor-
tion of animals from each birth cohort in the cattle
population of July 2015 at the defined geographical level.
We estimated the national seroprevalence in the cattle
population given the estimate of seroprevalence per
birth cohort as calculated above. We estimated this sero-
prevalence per département status: “BTV-infected in
2015” or “BTV-non-infected in 2015”. We used the
lower and upper limits of the 95% CI of the seropreva-
lence per each birth cohort to estimate the lower and
upper bounds of the confidence interval for cattle sero-
prevalence. No serological data were available for calves
less than 1 year old, but colostral antibodies are present
only a few months after birth. We therefore considered
them as naïve with a seroprevalence of 0%.
We estimated seroprevalence per region using the sero-
prevalence levels per birth cohort observed per region.
The objective was to assess the spatial variation of sero-
prevalence due to the spatial variation of the cattle popu-
lation and of the seroprevalence levels per birth cohort.
Finally, to estimate the seroprevalence of BT in cattle
at département level, we used the national seropreva-
lence levels for each birth cohort estimated for the area
considered free of BTV infection in order to exclude any
effects of the 2015 BTV circulation.
Proportion of infected cattle per birth period on infected
farms in autumn 2015 (RT-PCR)
In order to roughly estimate the likelihood of an animal
being infected in 2015 according to its birth cohort, we
calculated the proportion of RT-PCR positive animals
per birth cohort on infected farms in autumn 2015. We
used the results of two other surveys conducted in au-
tumn 2015, organised by the Ministry of Agriculture.
We used RT-PCR results from 609 cattle on ten farms
found to be infected during a survey conducted in Sep-
tember 2015. This survey targeted farms located within
2 km of the first BTV-8 outbreak detected in August
2015 in the Allier département. We also used results
from 768 cattle on 26 farms found to be infected during
a national cross-sectional survey conducted in
September-October 2015 testing 30 cattle per farm on
1338 farms. All these infected farms were located in cen-
tral France and were separated by a maximum distance
of 220 km. Therefore, we considered that these animals
were almost identically exposed to virus circulation in
2015 and were aggregated for the analysis of prevalence
per birth period.
Data on birth date and cattle movements were ex-
tracted from the National Identification Database
(BDNI). All analyses were performed using R software
version 3.1.2 [35]. The protocol was designed, and the
results analysed and interprated within the “BT working
group” of the French Platform for Epidemiological Sur-
veillance in Animal Health (“ESA Platform”).
Results
Estimates of seroprevalence in cattle per birth period and
the département’s BTV-8 status in 2015
A total of 8525 animals born before 2013 and 15,799 an-
imals born after 2013 from 55 départements were tested
by ELISA. Because of difficulties related to sample col-
lection, laboratory analyses or data recording, three
départements were excluded from the analysis (Fig. 1).
Among the sampled animals, 681 (2.8%) had left their
département of birth since July 2015 and were therefore
excluded from the analysis.
Nationally, we found large seroprevalence differences
according to birth periods (Chi2 = 16,950, df = 6, p <
0.001), with higher levels among the birth cohorts before
June 2009 (Table 3). No significant difference in sero-
prevalence was found between infected and non-infected
départements in 2015 among animals born before July
2010 (Table 3). A difference of 2% to 6% was observed
between infected and non-infected départements for ani-
mals born after July 2010. Similarly, a seroprevalence of
2-3% was also observed in animals born after July 2013
(animals that had never been vaccinated) and between
July 2012 and June 2013 (animals that had probably
never been vaccinated) in infected départements, while it
was very low (0.5%) in non-infected départements.
Seroprevalence was high (> 75%) among cattle that
were present during mandatory vaccination campaigns
in 2008-2010 and the period of intense BTV circulation
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in 2007-2009. It was lower for cattle born between July
2008 and July 2009 (76.6%, 95% CI [73.3 – 79.7]) than
those born before July 2008 (95.0%, 95% CI [94.0 –
95.9]) (Chi2 = 11, df = 1, p < 0.001). Seroprevalence in an-
imals born before 2008 did not vary greatly between re-
gions (difference of 13%) with a minimum of 85.6%
(Table 4). Conversely, a higher regional variability (differ-
ence of 25%) was observed for seroprevalence in cattle
born between July 2008 and July 2009 which varied be-
tween 65.7% and 90.4%, but with a lower precision (me-
dian of the 95% CI range of 20.9%, Table 4).
As expected, seroprevalence was lower (< 40%) for cat-
tle born in 2009-2010 and 2010-2011 (Table 3) given the
lower proportion of cattle vaccinated during the two vol-
untary vaccination campaigns in 2010-2012 (20-30% in
2010-2011). These animals were only present during vol-
untary vaccination campaigns or were less than
12 months old during the previous mandatory vaccin-
ation campaigns and therefore not necessarily vaccinated
at that time. Animals born in 2009-2010 had a sero-
prevalence of 32.3% (95% CI [29.3 – 35.4]) varying be-
tween 19.5 and 53.7% according to the region, whereas
those born in 2010-2011 had a seroprevalence of 12.8%
(95% CI [10.9 – 14.9]) varying between 1.1 and 21.7% ac-
cording to the region (Tables 3 and 4).
The proportion of doubtful ELISA results varied between
0.2 and 3.6% according to birth period (Table 3). A higher
proportion and a higher regional variability of doubtful re-
sults were observed for animals born between July 2008
and June 2010 (3.3% of doubtful results, which is signifi-
cantly different from other classes Chi2 = 233, df = 1, p-
value< 0.001; 4-8% of regional variability; Tables 3 and 4)
and those born between July 2010 and June 2012 (1.1% of
doubtful results, which is significantly different from other
classes Chi2 = 37, df = 1, p-value< 0.001; 2% of regional vari-
ability; Tables 3 and 4). This proportion was higher in in-
fected départements in 2015 than in non-infected ones for
cattle born between July 2010 and June 2012 (2.5% vs. 0.6%,
Chi2 = 15.6, df = 1, p-value< 0.001, Table 3).
Estimates of seroprevalence in the French cattle
population in 2015 at national, regional and département
levels
In July 2015, 59% of cattle in mainland France were born
after June 2012, including 29% of calves less than
12 months old. The proportion of animals born before
July 2008, in 2008-2009, 2009-2010, 2010-2011 and
2011-2012 was respectively 12%, 5%, 6%, 8% and 10%.
The structure of the cattle population varied per dépar-
tement but this was mainly due to the proportion of ani-
mals born before July 2008 (from 6.3% to 27%) and after
June 2012 (from 44% to 67%). For other birth cohorts,
smaller variations were reported (less than 5%).
We estimated a BT seroprevalence for the cattle popula-
tion of 18.5% [CI 17.6 - 19.4] and 19.6% [CI 18.2 - 21.1]
respectively in “non-infected” and “infected” départements
in 2015. When using seroprevalence levels observed for
each birth cohort per region, the proportion of seroposi-
tive animals per region in the cattle population of 2015
was estimated to range from 12.3% [10.8% – 14.6%] to
25.2% [22.3% – 28.1%] with a median of 15.7%. A higher
seroprevalence (> 20%) was observed in the Auvergne and
Aquitaine regions, where there was a higher proportion of
beef farms and a higher proportion of older animals (>
20% of animals born before 2008). When using national
seroprevalence figures per birth cohort, the seroprevalence
per département was estimated to vary from 12.4% [11.6%
– 13.2%] to 32.3% [31.3% – 33.2%] with a median of 18.1%
at département level (Fig. 2). There was an increasing
North-South gradient in the proportion of seropositive
cattle per département. In the Allier and Puy-de-Dôme
départements where BT outbreaks were mainly detected
in 2015-2016, the seroprevalence was estimated to be 20.1
and 23.3% respectively.
Proportion of infected cattle per birth period on infected
farms in autumn 2015
On infected farms in 2015, RT-PCR prevalence was the
highest in animals born between July 2012 and June
Table 3 BTV-8 seroprevalence in French cattle in the winter of 2015-2016 per birth cohort and the département’s BTV-8 status
Birth cohort BTV-8 non-infected départements BTV-8 infected départements
No.
analyses
ELISA positive ELISA doubtful No.
analyses
ELISA positive ELISA doubtful
No. % (CI 95%) No. % (CI 95%) No. % (CI 95%) No. % (CI 95%)
< July 2008 1310 1254 95.7 [94.5 - 96.8] 4 0.3 [0.1 - 0.8] 866 814 94.0 [92.2 - 95.5] 2 0.2 [0 - 0.8]
July 2008 - June 2009 467 368 78.8 [74.8 - 82.4] 16 3.4 [2.0 - 5.5] 226 163 72.1 [65.8 - 77.9] 9 4.0 [1.8 - 7.4]
July 2009 - June 2010 617 194 31.4 [27.8 - 35.3] 23 3.7 [2.4 - 5.5] 317 108 34.1 [28.9 - 39.6] 6 1.9 [0.7 - 4.1]
July 2010 - June 2011 718 76 10.6 [8.4 - 13.1] 7 1.0 [0.4 - 2.0] 438 72 16.4 [13.1 - 20.2] 10 2.3 [1.1 - 4.1]
July 2011 - June 2012 1134 37 3.3 [2.3 - 4.5] 5 0.4 [0.1 - 1.0] 710 57 8.0 [6.1 - 10.3] 13 1.8 [1.0 - 3.1]
July 2012 - June 2013 4342 37 0.9 [0.6 - 1.2] 15 0.3 [0.2 - 0.6] 3179 75 2.3 [1.9 - 2.9] 2 0.1 [0 - 0.2]
> June 2013* 5428 25 0.5 [0.4 - 0.7] 25 0.5 [0.3 - 0.7] 3891 102 2.6 [2.1 - 3.2] 5 0.1 [0 - 0.3]
*Cattle > 12 months old
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2013 (19%) and decreased in older birth cohorts down
to 0% for animals born before 2008 (Table 5).
Discussion
Despite two massive mandatory vaccination campaigns
in 2008-2010 where more than 90% of the cattle popula-
tion was vaccinated, BTV-8 was again detected in France
in 2015. We found an effect of birth cohorts on the
seroprevalence related to their difference in exposure
levels to BTV-8 or vaccination.
Our results suggest that BTV-8 circulation in 2015
was low and had little influence on the seroprevalence
observed in cattle in the winter of 2015-2016. Seropreva-
lence in animals born after the vaccination ban in June
2013 can be used as an indicator of the level of recent
viral circulation after this date. In départements where
BTV circulation was evidenced in 2015-2016, 3% of
those animals were seropositive. We observed similar
seroprevalence levels for animals born between July
2012 and June 2013, suggesting poor vaccination cover-
age in 2012-2013. The difference in seroprevalence ob-
served in the two birth cohorts of July 2010 to June
2012 between infected and non-infected départements
(around 5%) was similar to the seroprevalence observed
in young animals born after June 2012 in infected dépar-
tements (around 3%). In 2015 or earlier, the virus may
have been re-circulating in infected areas at a very low
level with a maximum cumulative proportion of infected
Table 4 BTV-8 seroprevalence in cattle in the winter of 2015-2016 per birth cohort and region in France
Birth cohort Proportion of positive results per region (%) Proportion of doubtful results per region (%)
Median Min - Max Range Median of the 95% CI range Median Min - Max Range Median of the 95% CI range
< July 2008 96.5 85.6 - 99.1 13.5 5.7 0.0 0.0 – 2.3 2.3 2.1
July 2008 - June 2009 75.4 65.7 – 90.4 24.7 20.9 3.6 1.2 – 5.4 4.2 10.5
July 2009 - June 2010 30.1 19.5 – 53.7 34.2 19.3 3.0 0.0 – 8.3 8.3 8.5
July 2010 - June 2011 11.9 1.1 – 21.7 20.6 13.4 1.6 0.0 – 3.6 3.6 4.5
July 2011 - June 2012 5.8 0.0 – 9.6 9.6 7.2 1.0 0.0 – 1.8 1.8 4.0
July 2012 - June 2013 1.0 0.2 – 4.6 2.6 1.7 0.0 0.0 - 1.4 1.4 0.6
> June 2013* 0.7 0.0 – 4.6 4.6 1.2 0.2 0.0 - 1.4 1.4 0.6
*Cattle > 12 months old
Fig. 2 Estimation of BTV seroprevalence in cattle per French département in July 2015
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animals of 5% in all départements infected in 2015-2016.
It is worth noting that seroprevalence in young animals
born after 2013 was higher (5-10%) in only two départe-
ments (Allier and Puy-de-Dôme in central France) con-
sidered as the epicentre of the 2015-2016 resurgence
(data not shown). A very low BTV circulation in winter
2014-2015 (< 5% of infected animals among those born
after the 2013 vaccination ban) has also been evidenced
by a recent study conducted in seven départements in-
cluding the Allier [8]. Therefore, although some départe-
ments in our study might be wrongly classified as non-
infected due to undetected current or past BTV circula-
tion, our study shows that viral circulation in 2015 did
not significantly increase the proportion of seropositive
animals. In these départements, the presence of BT anti-
bodies is more likely to be due to past natural infection
from 2007 to 2009 and/or vaccination from 2007 to
2012 and thus existed before the 2015 resurgence.
Seroprevalence was higher (more than 75%) for ani-
mals that were present during periods of intensive viral
circulation from 2007 to 2009 or mandatory vaccination
campaigns when 90% of cattle were vaccinated (i.e. ani-
mals born before July 2009) and lower for those only
present during voluntary campaigns. This is consistent
with previous reports of the long persistence of BTV-8
antibodies after natural infection or vaccination [18, 19,
21]. Our results suggest that high vaccination coverage
in 2008-2010 allowed the seroprevalence level over
mainland France to be homogenised, and most animals
born before July 2008 and vaccinated during two con-
secutive years (probably > 90%) still carried antibodies
six years later. Indeed, we found little variation in sero-
prevalence between regions (10–25%), similar to the re-
gional variation estimated for vaccination coverage in
2009-2010 (20%). This spatial variation is lower than
could be expected if the persistence of antibodies arises
only from natural infection, given the proportion of noti-
fied outbreaks with a strong spatial variation in 2007-
2009 (between 3.5 to 100% per region (MAAF unpub-
lished data)).
Being younger than 12 months during the period of
vaccination or the 2007/2009 epidemics appeared to
influence 2015-2016 seroprevalence levels. Only 32% of
animals born between July 2009 and June 2010 and thus
being less than 12 months old during the mandatory
vaccination campaign of 2009-2010 were seropositive,
whereas a large majority was considered to have been
vaccinated in 2009-2010 (> 90%). This proportion is
closer to the estimate of vaccination coverage in 2010-
2011 (around 30%). This “age effect” (i.e. cattle being
younger than 12 months during the period of vaccin-
ation or intense BTV circulation) can be explained by a
lower exposure to viral circulation and vaccination or by
the absence of a long-term immune response after vac-
cination or natural infection for some calves born to im-
mune dams (either infected or vaccinated) [34, 36]. Due
to the persistence of colostral antibodies that interfered
with the induction of the immune response after vaccin-
ation, Vitour et al. (2011) [34] predicted a vaccination
success rate of only 50% for calves of 5-6 months old
born to immune dams. As the requirement was to vac-
cinate all calves before they reached 6 months of age
and most of them were probably not re-vaccinated later
during the voluntary campaigns, it is likely that some of
them did not develop an effective immune response.
Similarly, among animals present during the two
mandatory vaccination campaigns, animals born within
the year of the first campaign from July 2008 to June
2009 presented a lower seroprevalence (77%) than those
aged more than 12 months (95%). In addition to the
“age effect” during the vaccination period, we also attrib-
uted this difference to a faster decline in antibodies
among animals vaccinated only once (prime and boost
injection against serotypes 1 and 8) compared to those
vaccinated twice. The higher proportion of doubtful re-
sults for animals born in 2008-2009 and 2009-2010 com-
pared to those born before 2008 might also suggest a
lower serological response and a shorter persistence of
antibodies in animals vaccinated only once. Although
this decline might be slightly faster, it is worth pointing
out that a high proportion of those animals still had
antibodies five years later.
We used group-specific cELISA to infer the immune
status of cattle towards BT although the level of
Table 5 RT-PCR results for cattle per birth cohort on farms found to be infected from September to October 2015 in France
Birth period No. analyses No. positives Proportion of positive results (% [95 CI])
< July 2008 201 0 0 [0 - 1.8]
July 2008 - June 2009 66 3 4.5 [0.9 - 12.7]
July 2009 - June 2010 89 6 6.7 [2.5 - 14.1]
July 2010 - June 2011 113 10 8.8 [4.3 - 15.7]
July 2011 - June 2012 177 24 13.5 [8.9 - 19.5]
July 2012 - June 2013 206 39 18.9 [13.8 – 25.0]
July 2013-September 2014 180 24 13.3 [8.7 – 19.2]
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antibodies detected is not type-specific and not directly
correlated to protection. Given that vaccination was di-
rected against both serotypes BTV-8 and BTV-1
throughout mainland France, ELISA-positive animals
can have antibodies against either or both serotypes. On
infected farms in autumn 2015, we found that older
birth cohorts were infected less frequently than younger
ones. As discussed above, we found in parallel that older
birth cohorts were also those having the highest propor-
tion of animals with pre-existing BT antibodies. None of
the animals born before 2008 for which we observed in
parallel high seroprevalence levels (> 95%) were found to
be infected, for example. Conversely, 19% of naive ani-
mals born in 2012-2013 were infected in autumn 2015.
These results suggest that most animals with pre-
existing group-specific BT antibodies detected by ELISA
were protected against BTV-8 infection in 2015. More-
over, the ID-VET ELISA kits used for 96% of the study’s
serological analyses offered both high sensitivity and spe-
cificity (> 99.8%) [37]. Therefore, we considered within
the framework of this study that the undetected propor-
tion of seropositive animals was probably low.
Given the respective proportion of animals per birth
cohort in the cattle population, we estimated that 18-
20% (resp. from 12 to 25%) of cattle were seropositive
and hence probably immune in 2015 at the national level
(resp. at the regional level). Our results indicated that
the regional variation in cattle seroprevalence in 2015
was due more to regional variations in the cattle’s age-
population structure than in seroprevalence per birth co-
hort. These regional seroprevalence variations are mostly
explained by the spatial variation in the proportion of
animals born before 2008 (from 6.7 to 18.3% per region),
highly seropositive, and in the proportion of naive young
animals born after 2012 (from 56.7 to 64.5% per region).
In considering only the spatial variation of the cattle
population structure, we estimated that from 12 to 32%
of the animals were approximately still seropositive and
probably immune to BTV-8 in 2015 at département level
before the resurgence. In central France, and more spe-
cifically in the Allier and Puy-de-Dôme départements,
where most BT outbreaks were detected in 2015-2016,
this proportion was estimated to be around 20% to 25%.
Estimates of the proportion of immune cattle followed
an increasing North-South gradient related to variations
in cattle population structure and livestock farming
types: most farms located in central and southern France
are beef cattle farms with a lower turn-over (older and
therefore immune cattle) compared to dairy cattle farms
located in northern and western France. In our estima-
tions, we considered all calves as naive whereas some of
them — born to seropositive dams — may have colostral
antibodies and hence be immune from re-infection. This
proportion was unknown, but by considering that only
calves less than 7 months old and born to dams born be-
fore 2009 might have colostral antibodies to BT, we
might have underestimated the overall seroprevalence in
the cattle population by not more than 10% (BDNI
data).
Conclusion
Our results indicate that at the time of t BTV-8 resur-
gence in 2015 in central France, the viral circulation in
naive animal birth cohorts was limited (seroprevalence
< 5-10%) and from 12% to 32% of the cattle population
was probably immune. The long persistence of BT anti-
bodies after natural infection or vaccination seems to
have maintained a large proportion of immune animals
in the cattle population which were protected from re-
infection for many years. In 2015, the proportion of im-
mune cattle seemed to be sufficiently high to limit BTV-
8 circulation. There is no reliable information on the
French sheep population to accurately estimate the
levels of the residual sheep herd immunity in 2015. Con-
sidering their lower number in France and lower attract-
iveness to Culicoides, it has probably contributed less to
slowing down BTV circulation than cattle herd immun-
ity. However, further studies with dynamic mathematical
modelling, for instance, might help to solve this issue.
The immunity of the cattle population would continue
to decrease along with the population turnover in non-
infected areas. Based on our results and the respective
proportion of each birth cohort in the cattle population
of 2016-2017, we can hypothesise that 6% to 9% of the
cattle population was still immune in those areas in
2016-2017. In the summer and autumn of 2016, the
lower herd immunity and the higher number of infection
sources may partly explain the higher BTV circulation
observed in 2016 than in 2015 (1200 outbreaks between
July and December 2016 vs. 284 outbreaks between Au-
gust 2015 and June 2016) [29].
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